since , in the past , results of therapeutic trials in plasma cell tumors in humans have paralleled results in this animal model , clinical trials of cis-dichlorodiammineplatinum in multiple myeloma appear warranted .
C0008838
cis-dichlorodiammineplatinum
C0026764
multiple